BIT
Click for more information
7.50% 3.7¢ biotron limited

Yes... grants to test drugs. Often it’s drugs that are owned by...

  1. J8
    14,524 Posts.
    lightbulb Created with Sketch. 817
    clock Created with Sketch.
    13/02/21
    23:34
    Post #: 50963767
    Yes... grants to test drugs. Often it’s drugs that are owned by companies. DYOR

    I would love to see Doherty come out with a treatment break through.....

    BIT won’t get a mention because the research was not about what they are doing. It’s not relevant at all.

    Also consider the date perhaps??


    I see others still drawing the bow with their links to highly normal stuff. Reeks of name dropping, that’s about all.
    BIT Price at posting: 7.2¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢ 		Change
-0.003(7.50%) 		Mkt cap ! $33.38M
Open High Low Value Volume
3.8¢ 4.0¢ 3.7¢ $13.74K 361.7K

Buyers (Bids)

No. Vol. Price($)
1 421052 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 19000 1
View Market Depth
Last trade - 15.39pm 05/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.